These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30396012)

  • 1. The Toll-Like Receptor 2 agonist PEG-Pam
    Ernest M; Hunja C; Arakura Y; Haraga Y; Abkallo HM; Zeng W; Jackson DC; Chua B; Culleton R
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):451-458. PubMed ID: 30396012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.
    Peng X; Keitany GJ; Vignali M; Chen L; Gibson C; Choi K; Huang F; Wang R
    J Immunol; 2014 Aug; 193(3):1268-77. PubMed ID: 24958899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage.
    Belnoue E; Voza T; Costa FT; Grüner AC; Mauduit M; Rosa DS; Depinay N; Kayibanda M; Vigário AM; Mazier D; Snounou G; Sinnis P; Rénia L
    J Immunol; 2008 Dec; 181(12):8552-8. PubMed ID: 19050274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intradermal route for inoculation of sporozoites of rodent malaria parasites for immunological studies.
    Inoue M; Culleton RL
    Parasite Immunol; 2011 Feb; 33(2):137-42. PubMed ID: 21226727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parasitostatic effect of maslinic acid. II. Survival increase and immune protection in lethal Plasmodium yoelii-infected mice.
    Moneriz C; Marín-García P; Bautista JM; Diez A; Puyet A
    Malar J; 2011 Apr; 10():103. PubMed ID: 21518429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TLR2 is activated by sporozoites and suppresses intrahepatic rodent malaria parasite development.
    Zheng H; Tan Z; Zhou T; Zhu F; Ding Y; Liu T; Wu Y; Xu W
    Sci Rep; 2015 Dec; 5():18239. PubMed ID: 26667391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment.
    Belnoue E; Costa FT; Frankenberg T; Vigário AM; Voza T; Leroy N; Rodrigues MM; Landau I; Snounou G; Rénia L
    J Immunol; 2004 Feb; 172(4):2487-95. PubMed ID: 14764721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii.
    Mout R; Xu ZD; Wolf AK; Jo Davisson V; Jarori GK
    Malar J; 2012 Feb; 11():54. PubMed ID: 22361388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.
    Labaied M; Harupa A; Dumpit RF; Coppens I; Mikolajczak SA; Kappe SH
    Infect Immun; 2007 Aug; 75(8):3758-68. PubMed ID: 17517871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive live sporozoites inoculation under arteether chemoprophylaxis confers protection against subsequent sporozoite challenge in rodent malaria model.
    Bhardwaj J; Siddiqui AJ; Goyal M; Prakash K; Soni A; Puri SK
    Acta Trop; 2016 Jun; 158():130-138. PubMed ID: 26925772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
    Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
    Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination using normal live sporozoites under drug treatment.
    Rénia L; Grüner AC; Mauduit M; Snounou G
    Methods Mol Biol; 2013; 923():567-76. PubMed ID: 22990805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes.
    Zhu F; Liu T; Zhao C; Lu X; Zhang J; Xu W
    J Immunol; 2017 Jan; 198(1):300-307. PubMed ID: 27903741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes.
    Tachibana M; Ishino T; Tsuboi T; Torii M
    Vaccine; 2018 Nov; 36(49):7463-7471. PubMed ID: 30420038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory role of toll-like receptors agonists in Plasmodium yoelii liver stage development.
    Chen J; Xu W; Zhou T; Ding Y; Duan J; Huang F
    Parasite Immunol; 2009 Aug; 31(8):466-73. PubMed ID: 19646211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites.
    Sack BK; Keitany GJ; Vaughan AM; Miller JL; Wang R; Kappe SH
    PLoS Pathog; 2015 May; 11(5):e1004855. PubMed ID: 25974076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily Plasmodium yoelii infective mosquito bites do not generate protection or suppress previous immunity against the liver stage.
    Pollock T; Leitao R; Galan-Rodriguez C; Wong KA; Rodriguez A
    Malar J; 2011 Apr; 10():97. PubMed ID: 21501513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
    Meister S; Plouffe DM; Kuhen KL; Bonamy GM; Wu T; Barnes SW; Bopp SE; Borboa R; Bright AT; Che J; Cohen S; Dharia NV; Gagaring K; Gettayacamin M; Gordon P; Groessl T; Kato N; Lee MC; McNamara CW; Fidock DA; Nagle A; Nam TG; Richmond W; Roland J; Rottmann M; Zhou B; Froissard P; Glynne RJ; Mazier D; Sattabongkot J; Schultz PG; Tuntland T; Walker JR; Zhou Y; Chatterjee A; Diagana TT; Winzeler EA
    Science; 2011 Dec; 334(6061):1372-7. PubMed ID: 22096101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.
    Low LM; Ssemaganda A; Liu XQ; Ho MF; Ozberk V; Fink J; Sundac L; Alcorn K; Morrison A; O'Callaghan K; Gerrard J; Stanisic DI; Good MF
    Infect Immun; 2019 Jan; 87(1):. PubMed ID: 30323025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.